BIOPHEN™ DiXaI — Two-Stage Anti-Xa for Direct Xa Inhibitors
Processing...

BIOPHEN™ DiXaI — Two-Stage Anti-Xa for Direct Xa Inhibitors

Code: A221030-CAN
Manufacturer’s Part Number: 221030
Product size: Kit
Clearance: CE / HCL
Price: $420.00
Qty
 

Product Description

Two-stage chromogenic anti-Xa method specifically designed for the quantitative measurement of direct Factor Xa inhibitors (DiXaIs) in citrated human plasma: Rivaroxaban (Xarelto®), Apixaban (Eliquis®), and Edoxaban (Lixiana®).

Important: This method is NOT suitable for indirect inhibitors such as heparins or Fondaparinux. Use BIOPHEN™ Heparin LRT (ref. 221011/221013/221015) for those analytes.

  • Two-stage method provides high DiXaI specificity not achievable with one-stage anti-Xa assays
  • Dedicated calibrator and control plasmas for each drug (Rivaroxaban, Apixaban, Edoxaban)
  • Use with Tris-NaCl-EDTA buffer (ref. AR032K) to reduce heparin interference in mixed samples
  • CE-IVD

Product Characteristics

  • Total Assay Time: < 10 min
  • Dynamic Range:
      Standard Range (Rivaroxaban): 0 to 500 ng/mL
      Low Range (Rivaroxaban): 0 to 100 ng/mL
      Standard Range (Apixaban): 0 to 600 ng/mL
      Low Range (Apixaban): 0 to 120 ng/mL
  • Number of Tests (Manual Method): 3 x 10 Tests

Product Components

  • R1: 3 x 2.5 mL purified human FXa, lyophilized.
  • R2: 3 x 2.5 mL FXa chromogenic substrate, lyophilized.
  • R3: 4 x 20 mL Tris-NaCl-EDTA-PEG Buffer, pH 7.85. Ready to use.
  

Product Applications

For the measurement of Rivaroxaban, Apixaban, and other direct Factor Xa inhibitors in research applications.

Please Note: IVD Not for Sale in US. For US availability CLICK HERE.

Instructions For Use

Material Safety Data Sheet (MSDS)

Data Sheet/Technical Data

Certificate of Analysis (COA)

Other Documents

  

Related Products

Code Name Price  
A221030-RUO BIOPHEN™ DiXaI — Two-Stage Anti-Xa for Direct Xa Inhibitors    $440.00